Publication | Open Access
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
185
Citations
17
References
2019
Year
After achieving normokalemia, individualized once daily sodium zirconium cyclosilicate was associated with maintenance of normokalemia without substantial renin-angiotensin-aldosterone system inhibitor changes for ≤12 months.
| Year | Citations | |
|---|---|---|
Page 1
Page 1